Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

Imagine: A rare disease that’s rarely diagnosed because it mimics so many other diseases. We’re talking about Alpha-1 antitrypsin deficiency or AAT, a hereditary condition that may cause lung disease and liver disease. Dr. Kyle Hogarth, a pulmonologist at the University of Chicago, joins us to discuss the disease. Who’s at risk of getting this condition? What tests determine if you have it? And what lifestyle changes can help patients cope with this disease? We have lots of insight.

Clinical trials are an opportunity for patients to receive promising new therapies, but they can be difficult to navigate. Learn how The Leukemia & Lymphoma Society’s Clinical Trial Support Center is helping guide patients.

There are approximately 7,000 known rare diseases, but only 5% of them have an approved treatment. Learn how early intervention, proper management strategies, and clinical trials are key for rare disease patients. 

Friedreich’s Ataxia is a progressive and debilitating neurological disorder. It's important to recognize symptoms and obtain an early diagnosis to properly manage the condition.

Comments

comments